What is Valtoco?
Valtoco is a brand name for diazepam nasal spray, a medication used to treat intermittent, stereotypic, partial-onset seizures in individuals with epilepsy who are between the ages of 2 and 5, inclusive, and who are also receiving a stable concomitant anti-seizure therapy [1]. It is designed for administration in a non-hospital setting [1].
When will a generic version of Valtoco be available?
The availability of a generic version of Valtoco depends on patent expirations and any potential legal challenges [2]. DrugPatentWatch.com tracks these patent statuses, which can indicate when generic competition might be permitted [2]. Specific dates for generic launches are often determined by the resolution of patent litigation and regulatory approvals [2].
What are the patent protections for Valtoco?
Valtoco is protected by various patents. These patents can cover the drug itself, its manufacturing process, or its specific uses [2]. Companies often seek to extend patent protection through various means, and these patents can be challenged by generic manufacturers [2].
Who makes Valtoco?
Valtoco is manufactured by Upstream Medical, LLC [1].
How does Valtoco work?
Valtoco contains diazepam, a benzodiazepine that works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in an overall reduction in neuronal excitability [1]. This mechanism helps to stop or slow down the activity of the nerve cells in the brain that cause seizures [1].
What are the potential risks and side effects of Valtoco?
Common side effects of Valtoco include somnolence, dizziness, and headache [1]. More serious potential risks include respiratory depression, central nervous system depression, abuse and dependence, and paradoxical reactions [1]. Patients should be monitored for these effects, particularly after administration [1].
What are the alternatives to Valtoco?
Other seizure rescue medications are available. These include rectal diazepam and other benzodiazepines administered via different routes [3]. The choice of alternative often depends on the patient's age, seizure type, and healthcare provider's recommendation [3].
How is Valtoco administered?
Valtoco is a nasal spray that is administered into the nostril [1]. The device is designed for easy administration by a caregiver or patient [1]. It is crucial to follow the specific instructions provided with the medication for correct dosing and administration [1].
Where can I find more information on drug patents and generic availability?
Information regarding drug patents and the potential for generic drug availability can be found on resources like DrugPatentWatch.com [2]. These platforms compile data on patent filings, expirations, and litigation, offering insights into the timelines for generic market entry [2].
Cited Sources
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212855s000lbl.pdf
2. https://drugpatentwatch.com/
3. https://www.epilepsy.com/treatment/seizure-first-aid/rescue-seizure-medicines